| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |